Erste Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5M | Hold |
20,300
| – | – | 0.03% | 317 |
|
|
2025
Q1 | $3.14M | Hold |
20,300
| – | – | 0.04% | 259 |
|
|
2024
Q4 | $2.79M | Hold |
20,300
| – | – | 0.03% | 288 |
|
|
2024
Q3 | $2.94M | Buy |
20,300
+1,800
| +10% | +$260K | 0.04% | 279 |
|
|
2024
Q2 | $2.5M | Hold |
18,500
| – | – | 0.03% | 287 |
|
|
2024
Q1 | $2.75M | Hold |
18,500
| – | – | 0.04% | 277 |
|
|
2023
Q4 | $2.36M | Hold |
18,500
| – | – | 0.03% | 277 |
|
|
2023
Q3 | $1.76M | Hold |
18,500
| – | – | 0.03% | 286 |
|
|
2023
Q2 | $1.62M | Hold |
18,500
| – | – | 0.03% | 305 |
|
|
2023
Q1 | $2.01M | Hold |
18,500
| – | – | 0.04% | 286 |
|
|
2022
Q4 | $2.24M | Buy |
18,500
+7,400
| +67% | +$895K | 0.05% | 269 |
|
|
2022
Q3 | $1.14M | Hold |
11,100
| – | – | 0.03% | 339 |
|
|
2022
Q2 | $1.05M | Hold |
11,100
| – | – | 0.02% | 350 |
|
|
2022
Q1 | $1.29M | Sell |
11,100
-2,900
| -21% | -$336K | 0.02% | 336 |
|
|
2021
Q4 | $1.87M | Hold |
14,000
| – | – | 0.03% | 298 |
|
|
2021
Q3 | $2.2M | Hold |
14,000
| – | – | 0.04% | 266 |
|
|
2021
Q2 | $1.88M | Hold |
14,000
| – | – | 0.04% | 289 |
|
|
2021
Q1 | $1.8M | Hold |
14,000
| – | – | 0.04% | 282 |
|
|
2020
Q4 | $2.33M | Buy |
+14,000
| New | +$2.33M | 0.06% | 248 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 464 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 446 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 430 |
|